{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:43:58Z","timestamp":1788918238340,"version":"build-2803163510"},"reference-count":38,"publisher":"CMA Joule Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.9778\/cmajo.20200219","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T12:58:58Z","timestamp":1634648338000},"page":"E948-E956","source":"Crossref","is-referenced-by-count":23,"title":["Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study"],"prefix":"10.9778","volume":"9","author":[{"given":"Nisha","family":"Thampi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden D.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kednapa","family":"Thavorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Lanctot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hawken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Dayre","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"2021101905350761000_9.4.E948.1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/INF.0000000000002164","article-title":"Characteristics and outcomes of young children hospitalized with laboratory-confirmed influenza or respiratory syncytial virus in Ontario, Canada, 2009\u20132014","volume":"38","author":"Buchan","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2021101905350761000_9.4.E948.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804877"},{"key":"2021101905350761000_9.4.E948.3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/cid\/ciz157","article-title":"Epidemiology, risk factors, and outcomes of respiratory syncytial virus infections in newborns in Bamako, Mali","volume":"70","author":"Buchwald","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021101905350761000_9.4.E948.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30938-8"},{"key":"2021101905350761000_9.4.E948.5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0303"},{"key":"2021101905350761000_9.4.E948.6","doi-asserted-by":"crossref","first-page":"e0150416","DOI":"10.1371\/journal.pone.0150416","article-title":"Incidence of hospitalization for respiratory syncytial virus infection amongst children in Ontario, Canada: a population-based study using validated health administrative data","volume":"11","author":"Pisesky","year":"2016","journal-title":"PLoS One"},{"key":"2021101905350761000_9.4.E948.7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit839"},{"key":"2021101905350761000_9.4.E948.8","doi-asserted-by":"publisher","DOI":"10.1080\/08035250510046812"},{"key":"2021101905350761000_9.4.E948.9","unstructured":"(2018) Product Monograph: PrSYNAGIS (Health Canada, Ottawa) Available: https:\/\/pdf.hres.ca\/dpd_pm\/00050014.PDF . accessed 2020 Sept. 11."},{"key":"2021101905350761000_9.4.E948.10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531"},{"key":"2021101905350761000_9.4.E948.11","unstructured":"(2017) RSV vaccine research and development technology roadmap: Priority activities for development, testing, licensure and global use of RSV vaccines, with a specific focus on the medical need for young children in low-and middle-income countries (World Health Organization, Geneva)."},{"key":"2021101905350761000_9.4.E948.12","unstructured":"Exchange rates (Bank of Canada, Ottawa) Available: https:\/\/www.bankofcanada.ca\/rates\/exchange . accessed 2021 Jan. 29."},{"key":"2021101905350761000_9.4.E948.13","unstructured":"Inflation Calculator (Bank of Canada, Ottawa) Available: https:\/\/www.bankofcanada.ca\/rates\/related\/inflation-calculator\/ . accessed 2021 Jan. 28."},{"key":"2021101905350761000_9.4.E948.14","unstructured":"Inflation Calculator CPI (U.S. Bureau of Labor Statistics, Washington (DC)) Available: https:\/\/www.bls.gov\/data\/inflation_calculator.htm . accessed 2021 Jan. 29."},{"key":"2021101905350761000_9.4.E948.15","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1016\/j.vaccine.2018.09.029","article-title":"Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France","volume":"36","author":"Kramer","year":"2018","journal-title":"Vaccine"},{"key":"2021101905350761000_9.4.E948.16","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2016.113"},{"key":"2021101905350761000_9.4.E948.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.072"},{"key":"2021101905350761000_9.4.E948.18","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21244"},{"key":"2021101905350761000_9.4.E948.19","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000129690.35341.8d"},{"key":"2021101905350761000_9.4.E948.20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13696998.2019.1658592","article-title":"Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants","volume":"23","author":"Ledbetter","year":"2020","journal-title":"J Med Econ"},{"key":"2021101905350761000_9.4.E948.21","unstructured":"Wodchis WP Bushmeneva K Nikitovic M (2013) Guidelines on person-level costing using administrative databases in Ontario (University of Toronto Libraries, Toronto) Available: https:\/\/tspace.library.utoronto.ca\/handle\/1807\/87373 . accessed 2020 Sept. 11."},{"key":"2021101905350761000_9.4.E948.22","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2011.578188"},{"key":"2021101905350761000_9.4.E948.23","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3263"},{"key":"2021101905350761000_9.4.E948.24","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X08315238"},{"key":"2021101905350761000_9.4.E948.25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-199"},{"key":"2021101905350761000_9.4.E948.26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PCC.0000000000001164","article-title":"Increased mortality and length of stay associated with medical emergency team review in hospitalized pediatric patients: a retrospective cohort study","volume":"18","author":"McKelvie","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"2021101905350761000_9.4.E948.27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3877"},{"key":"2021101905350761000_9.4.E948.28","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20150052"},{"key":"2021101905350761000_9.4.E948.29","doi-asserted-by":"crossref","first-page":"523.e11","DOI":"10.1016\/j.cjca.2010.12.064","article-title":"Economic evaluation of palivizumab in children with congenital heart disease: a Canadian perspective","volume":"27","author":"Harris","year":"2011","journal-title":"Can J Cardiol"},{"key":"2021101905350761000_9.4.E948.30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/21645515.2016.1235670","article-title":"The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: a decision analysis model","volume":"13","author":"McGirr","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2021101905350761000_9.4.E948.31","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2010.535577"},{"key":"2021101905350761000_9.4.E948.32","doi-asserted-by":"publisher","DOI":"10.3111\/13696990903442155"},{"key":"2021101905350761000_9.4.E948.33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-4064"},{"key":"2021101905350761000_9.4.E948.34","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2468-2667(17)30103-2","article-title":"Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England","volume":"2","author":"Cromer","year":"2017","journal-title":"Lancet Public Health"},{"key":"2021101905350761000_9.4.E948.35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/ciy413","article-title":"Pediatric Investigators Collaborative Network on Infections in Canada study of respiratory syncytial virus-associated deaths in pediatric patients in Canada, 2003\u20132013","volume":"68","author":"Tam","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021101905350761000_9.4.E948.36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz278"},{"key":"2021101905350761000_9.4.E948.37","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31819df78e"},{"key":"2021101905350761000_9.4.E948.38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0039-1681014","article-title":"SENTINEL1: two-season study of respiratory syncytial virus hospitalizations among U.S. infants born at 29 to 35 weeks\u2019 gestational age not receiving immunoprophylaxis","volume":"37","author":"Anderson","year":"2020","journal-title":"Am J Perinatol"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20200219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T14:40:14Z","timestamp":1634654414000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20200219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,10,19]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.9778\/cmajo.20200219"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20200219","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}